Tuesday, June 23, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 608 of 1,261
  1. US 9763984

    Methods for production of platelets from pluripotent stem cells and compositions thereof

    Astellas Institute for Regenerative Medicine · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  2. US 9763993

    Process for manufacturing glatiramer acetate product

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  3. US 9763995

    Polymer conjugates of protegrin peptides

    Nektar Therapeutics · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  4. US 9763974

    Galacto-rhamnogalacturonate compositions for the treatment of diseases associated with elevated inducible nitric oxide synthase

    GALECTIN THERAPEUTICS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  5. US 9765378

    Preparation method of new recombinant antibacterial polypeptide medicine

    Creative Trio Biotech (Beijing) Co., Ltd. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  6. US 9764953

    Peptoids useful for the mineralization of apatite

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  7. US 9763925

    Antibacterial compounds

    SUMMIT THERAPEUTICS PLC · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  8. US 9765342

    Chimeric antigen receptors targeting B-cell maturation antigen

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  9. US 9763444

    Compositions and methods for repelling blood-sucking and biting insects, ticks and mites

    The United States of America, as represented by the Secretary of Agriculture · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  10. US 9763904

    Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds

    TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  11. US 9764001

    Target for diagnosis and treatment of diabetes and cardiovascular diseases

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  12. US 9764305

    Geometry enhancement of nanoscale energy deposition by X-rays

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  13. US 9763883

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  14. US 9763982

    Depletion of cancer stem cells

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  15. US 9763987

    Cyclic di-AMP induction of type I interferon

    The Regents of the University of California · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  16. US 9765027

    Substituted 1-arylethyl-4-acylaminopiperidine derivatives as opioid/alpha-adrenoreceptor modulators and method of their preparation

    Arizona Board of Regents on Behalf of the University of Arizona · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  17. US 9765053

    Methods of treatment using selective 5-HT2A inverse agonists

    ACADIA Pharmaceuticals Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  18. US 9765066

    Selective HDAC1 and HDAC2 inhibitors

    Regenacy Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  19. US 9765087

    Benzimidazole derivatives

    Enanta Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  20. US 9765099

    STAT6 inhibitors

    The Board of Regents of the University of Texas System · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  21. US 9765142

    TEM8 antibodies and their use in treatment and detection of tumors

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  22. US 9765302

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  23. US 9765338

    Modulation of dystrophia myotonica-protein kinase (DMPK) expression

    Ionis Pharmaceuticals, Inc. · Granted Sep 19, 2017 · Expires Sep 14, 2037

    granted
  24. US 2017260158

    QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR

    ABBVIE DEUTSCHLAND [DE] · Granted Sep 14, 2017 · Expires Sep 9, 2037

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.